News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kendall Law Group Investigates ev3 Inc. (EVVV) Merger for Shareholders


6/1/2010 4:24:53 PM

DALLAS--(BUSINESS WIRE)--Kendall Law Group, a national securities firm, is investigating ev3, Inc. (NASDAQ: EVVV) for shareholders in connection with the proposed sale of ev3 to Covidien, plc. (NYSE: COV). The firm’s investigation seeks to determine whether ev3 and its Board breached their fiduciary duties by entering into the agreement without properly shopping for a deal that would provide better value for shareholders. If you are an ev3 shareholder and would like additional information about your rights, contact the Kendall Law Group at 877-744-3728 or by email at skendall@kendalllawgroup.com.

Read at BioSpace.com

comments powered by Disqus
ev3 Inc.
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES